ABCAM Plc Annual Financial Report (6154R)
September 22 2017 - 10:32AM
UK Regulatory
TIDMABC
RNS Number : 6154R
ABCAM Plc
22 September 2017
For immediate release 22 September 2017
ABCAM PLC
("Abcam")
Posting of Annual Report and Accounts
Cambridge, UK: Abcam plc (AIM: ABC), a global leader in the
supply of life science research tools, announces that its Annual
Report and Accounts for the year ended 30 June 2017 has been posted
to shareholders and is available at the Company's investor
relations website, www.abcamplc.com.
For further information, please contact:
Abcam plc
Suzanne Smith, Company Secretary + 44 (0) 1223
Julia Wilson, Investor Relations 696 000
J.P.Morgan Cazenove - Nominated + 44 (0) 20
Adviser & Corporate Broker 7742 4000
James Mitford / Candelle Chong
FTI Consulting
Ben Atwell / Brett Pollard / Natalie +44 (0) 20
Garland-Collins 3727 1000
Notes to Editors
About Abcam plc
As an innovator in reagents and tools, Abcam's purpose is to
serve life science researchers globally to achieve their mission,
faster. Providing the research and clinical communities with tools
and scientific support, the Company offers highly validated
biological binders and assays to address important targets in
critical biological pathways.
Already a pioneer in data sharing and ecommerce in the life
sciences, Abcam's ambition is to be the most influential company in
life sciences by helping advance global understanding of biology
and causes of disease which, in turn, will drive new treatments and
improved health. Two-thirds of the world's 750,000 life science
researchers use Abcam's affinity binders, reagents, biomarkers and
assays and the Company's products are mentioned in over 20,000 of
the 56,000 peer-reviewed papers published each year in the life
sciences.
By actively listening to and collaborating with researchers, the
Company continuously advances its portfolio to address their needs.
A transparent programme of customer reviews and datasheets,
combined with an industry-leading validation initiative, gives
researchers increased confidence in their results.
Abcam's twelve locations are in the world's leading life science
research hubs, enabling local services and multi-language support.
Founded in 1998 and headquartered in Cambridge, UK, the Company
sells to more than 100 countries. Abcam was admitted to AIM in 2005
(AIM: ABC).
To find out more, please visit www.abcam.com and
www.abcamplc.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
ACSOKBDNQBKDKCB
(END) Dow Jones Newswires
September 22, 2017 10:32 ET (14:32 GMT)
Abcam (LSE:ABC)
Historical Stock Chart
From Apr 2024 to May 2024
Abcam (LSE:ABC)
Historical Stock Chart
From May 2023 to May 2024